Hepatitis C Articles (HCV)
Back
	New HCV Drug - NNI CC-31244     Clinical Pharmacokinetics and Antiviral Activity of CC-31244, a Pan-genotypic, Potent Nonnucleoside NS5B Polymerase Inhibitor (NNI) for the Treatment of Hepatitis C - (02/21/17)   Cocrystal Pharma Updates New HCV Drugs Development...http://www.natap.org/2016/HCV/081016_02.htm   New HCV Drugs - Helicase Inhibitor - Cocrystal Pharma....http://www.natap.org/2016/HCV/090716_04.htm             View Older Articles   Back to Top   www.natap.org